Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 11,032 | 11,251 | 9,714 | 21,614 | 23,950 |
| Gross Profit | 11,032 | 11,251 | 9,714 | 21,614 | 23,950 |
| Operating Expenses | 102,343 | 77,739 | 77,310 | 69,191 | 71,539 |
| Operating Income | -91,311 | -66,488 | -67,596 | -47,577 | -47,589 |
| Interest Expense | 35 | 0 | 2,351 | 1,957 | 1,654 |
| Other Income | 624 | -232 | -2 | 937 | -8,065 |
| Pre-tax Income | -90,722 | -66,720 | -69,949 | -48,597 | -57,308 |
| Net Income Continuous | -90,722 | -66,720 | -69,949 | -48,597 | -57,308 |
| Net Income | $-90,722 | $-66,720 | $-69,949 | $-48,597 | $-57,308 |
| EPS Basic Total Ops | -3.45 | -3.83 | -4.10 | -3.90 | -6.90 |
| EPS Basic Continuous Ops | -3.45 | -3.40 | -4.10 | -3.88 | -6.95 |
| EPS Diluted Total Ops | -3.45 | -3.83 | -4.10 | -3.90 | -6.90 |
| EPS Diluted Continuous Ops | -3.45 | -3.40 | -4.10 | -3.88 | -6.95 |
| EBITDA(a) | $-89,026 | $-64,238 | $-65,091 | $-44,803 | $-44,827 |